Prospective Follow-Up of Novel Markers of Bone Turnover in Persistent Asthmatics Exposed to Low and High Doses of Inhaled Ciclesonide over 12 Months | Zendy

William J. Anderson | Zendy; Lesley C. McFarlane | Zendy; Brian J. Lipworth | Zendy

Open Access

Prospective Follow-Up of Novel Markers of Bone Turnover in Persistent Asthmatics Exposed to Low and High Doses of Inhaled Ciclesonide over 12 Months

Author(s) -

William J. Anderson,

Lesley C. McFarlane,

Brian J. Lipworth

Publication year - 2012

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2011-3410

Subject(s) - medicine , n terminal telopeptide , ciclesonide , bone remodeling , bone resorption , endocrinology , asthma , gastroenterology , adverse effect , prospective cohort study , osteocalcin , alkaline phosphatase , biochemistry , chemistry , inhaled corticosteroids , enzyme

In asthmatic patients receiving long-term inhaled corticosteroid therapy, there are concerns regarding the potential for developing systemic adverse effects on bone metabolism, possibly even in the absence of adrenal suppression.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research